{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:52:36Z","timestamp":1792857156956,"version":"4.5.0"},"reference-count":305,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s12035-008-8036-x","type":"journal-article","created":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T14:58:13Z","timestamp":1218034693000},"page":"78-100","source":"Crossref","is-referenced-by-count":335,"title":["Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration"],"prefix":"10.1007","volume":"38","author":[{"given":"P. S.","family":"Vosler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,7]]},"reference":[{"key":"8036_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1527-3458.2006.00135.x","volume":"12","author":"A Camins","year":"2006","unstructured":"Camins A (2006) Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev 12:135\u2013148","journal-title":"CNS Drug Rev"},{"key":"8036_CR2","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.2174\/092986706779010342","volume":"13","author":"SK Ray","year":"2006","unstructured":"Ray SK (2006) Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia. Curr Med Chem 13:3425\u20133440","journal-title":"Curr Med Chem"},{"key":"8036_CR3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.drudis.2006.08.009","volume":"11","author":"ME Saez","year":"2006","unstructured":"Saez ME (2006) The therapeutic potential of the calpain family: new aspects. Drug Discov Today 11:917\u2013923","journal-title":"Drug Discov Today"},{"key":"8036_CR4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00029.2002","volume":"83","author":"DE Goll","year":"2003","unstructured":"Goll DE (2003) The calpain system. Physiol Rev 83:731\u2013801","journal-title":"Physiol Rev"},{"key":"8036_CR5","first-page":"123","volume":"61","author":"HY Wu","year":"2007","unstructured":"Wu HY (2007) Calpain\u2013calcineurin signaling in the pathogenesis of calcium-dependent disorder. Acta Med Okayama 61:123\u2013137","journal-title":"Acta Med Okayama"},{"key":"8036_CR6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nsb0797-532","volume":"4","author":"H Blanchard","year":"1997","unstructured":"Blanchard H (1997) Structure of a calpain Ca(2+)-binding domain reveals a novel EF-hand and Ca(2+)-induced conformational changes. Nat Struct Biol 4:532\u2013538","journal-title":"Nat Struct Biol"},{"key":"8036_CR7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.jcbfm.9600595","volume":"28","author":"MB Bevers","year":"2008","unstructured":"Bevers MB (2008) Mechanistic role of calpains in postischemic neurodegeneration. J Cereb Blood Flow Metab 28:655\u2013673","journal-title":"J Cereb Blood Flow Metab"},{"key":"8036_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K","volume":"58","author":"SL Chan","year":"1999","unstructured":"Chan SL (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 58:167\u2013190","journal-title":"J Neurosci Res"},{"key":"8036_CR9","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1523\/JNEUROSCI.17-17-06669.1997","volume":"17","author":"K Hyrc","year":"1997","unstructured":"Hyrc K (1997) Ionized intracellular calcium concentration predicts excitotoxic neuronal death: observations with low-affinity fluorescent calcium indicators. J Neurosci 17:6669\u20136677","journal-title":"J Neurosci"},{"key":"8036_CR10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/bies.950140810","volume":"14","author":"DE Goll","year":"1992","unstructured":"Goll DE (1992) Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays 14:549\u2013556","journal-title":"Bioessays"},{"key":"8036_CR11","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/MCB.20.12.4474-4481.2000","volume":"20","author":"JS Arthur","year":"2000","unstructured":"Arthur JS (2000) Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 20:4474\u20134481","journal-title":"Mol Cell Biol"},{"key":"8036_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-213X-6-3","volume":"6","author":"P Dutt","year":"2006","unstructured":"Dutt P (2006) m-Calpain is required for preimplantation embryonic development in mice. BMC Dev Biol 6:3","journal-title":"BMC Dev Biol"},{"key":"8036_CR13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0006-291X(92)91259-S","volume":"187","author":"S Pontremoli","year":"1992","unstructured":"Pontremoli S (1992) Modulation of inhibitory efficiency of rat skeletal muscle calpastatin by phosphorylation. Biochem Biophys Res Commun 187:751\u2013759","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(88)90181-6","volume":"262","author":"GN DeMartino","year":"1988","unstructured":"DeMartino GN (1988) Proteolysis of the protein inhibitor of calcium-dependent proteases produces lower molecular weight fragments that retain inhibitory activity. Arch Biochem Biophys 262:189\u2013198","journal-title":"Arch Biochem Biophys"},{"key":"8036_CR15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00018-005-5097-0","volume":"62","author":"A Czogalla","year":"2005","unstructured":"Czogalla A (2005) Spectrin and calpain: a \u2018target\u2019 and a \u2018sniper\u2019 in the pathology of neuronal cells. Cell Mol Life Sci 62:1913\u20131924","journal-title":"Cell Mol Life Sci"},{"key":"8036_CR16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1523\/JNEUROSCI.06-05-01264.1986","volume":"6","author":"RA Nixon","year":"1986","unstructured":"Nixon RA (1986) Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activities in neurons. J Neurosci 6:1264\u20131271","journal-title":"J Neurosci"},{"key":"8036_CR17","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1073\/pnas.81.11.3572","volume":"81","author":"R Siman","year":"1984","unstructured":"Siman R (1984) Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease. Proc Natl Acad Sci U S A 81:3572\u20133576","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/syn.890010105","volume":"1","author":"P Seubert","year":"1987","unstructured":"Seubert P (1987) Calmodulin stimulates the degradation of brain spectrin by calpain. Synapse 1:20\u201324","journal-title":"Synapse"},{"key":"8036_CR19","doi-asserted-by":"crossref","first-page":"40632","DOI":"10.1074\/jbc.M506870200","volume":"280","author":"D Cuerrier","year":"2005","unstructured":"Cuerrier D (2005) Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions. J Biol Chem 280:40632\u201340641","journal-title":"J Biol Chem"},{"key":"8036_CR20","doi-asserted-by":"crossref","first-page":"20775","DOI":"10.1074\/jbc.M313873200","volume":"279","author":"P Tompa","year":"2004","unstructured":"Tompa P (2004) On the sequential determinants of calpain cleavage. J Biol Chem 279:20775\u201320785","journal-title":"J Biol Chem"},{"key":"8036_CR21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJMcp072057","volume":"357","author":"HB Worp van der","year":"2007","unstructured":"van der Worp HB (2007) Clinical practice. Acute ischemic stroke. N Engl J Med 357:572\u2013579","journal-title":"N Engl J Med"},{"key":"8036_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2005.10.004","volume":"24","author":"I Harukuni","year":"2006","unstructured":"Harukuni I (2006) Mechanisms of brain injury after global cerebral ischemia. Neurol Clin 24:1\u201321","journal-title":"Neurol Clin"},{"key":"8036_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.pharmtox.47.120505.105311","volume":"47","author":"MR Hara","year":"2007","unstructured":"Hara MR (2007) Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol 47:117\u201341","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"8036_CR24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.164.3880.719","volume":"164","author":"JW Olney","year":"1969","unstructured":"Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719\u2013721","journal-title":"Science"},{"key":"8036_CR25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/neu.480230915","volume":"23","author":"DW Choi","year":"1992","unstructured":"Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:1261\u20131276","journal-title":"J Neurobiol"},{"key":"8036_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0896-6273(88)90076-1","volume":"1","author":"R Siman","year":"1988","unstructured":"Siman R (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279\u2013287","journal-title":"Neuron"},{"key":"8036_CR27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.STR.25.3.663","volume":"25","author":"SC Hong","year":"1994","unstructured":"Hong SC (1994) Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25:663\u2013669","journal-title":"Stroke"},{"issue":"4","key":"8036_CR28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.jcbfm.9600595","volume":"28","author":"MB Bevers","year":"2007","unstructured":"Bevers MB (2007) Mechanistic role of calpains in postischemic neurodegeneration. J Cereb Blood Flow Metab 28(4):655\u2013673","journal-title":"J Cereb Blood Flow Metab"},{"key":"8036_CR29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00004647-200111000-00004","volume":"21","author":"JK Newcomb-Fernandez","year":"2001","unstructured":"Newcomb-Fernandez JK (2001) Concurrent assessment of calpain and caspase-3 activation after oxygen\u2013glucose deprivation in primary septo-hippocampal cultures. J Cereb Blood Flow Metab 21:1281\u20131294","journal-title":"J Cereb Blood Flow Metab"},{"key":"8036_CR30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/bbrc.1999.1315","volume":"263","author":"KM McGinnis","year":"1999","unstructured":"McGinnis KM (1999) Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem Biophys Res Commun 263:94\u201399","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2005.01.028","volume":"20","author":"C Malagelada","year":"2005","unstructured":"Malagelada C (2005) Contribution of caspase-mediated apoptosis to the cell death caused by oxygen\u2013glucose deprivation in cortical cell cultures. Neurobiol Dis 20:27\u201337","journal-title":"Neurobiol Dis"},{"key":"8036_CR32","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1046\/j.1460-9568.1998.00184.x","volume":"10","author":"T Yamashima","year":"1998","unstructured":"Yamashima T (1998) Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on \u2018calpain\u2013cathepsin hypothesis\u2019. Eur J Neurosci 10:1723\u20131733","journal-title":"Eur J Neurosci"},{"key":"8036_CR33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hipo.10127","volume":"13","author":"T Yamashima","year":"2003","unstructured":"Yamashima T (2003) Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus 13:791\u2013800","journal-title":"Hippocampus"},{"key":"8036_CR34","doi-asserted-by":"crossref","unstructured":"Chaitanya GV (2008) Activation of calpain, cathepsin-b and caspase-3 during transient focal cerebral ischemia in rat model. Neurochem Res. doi: 10.1007\/s11064-007-9567-7","DOI":"10.1007\/s11064-007-9567-7"},{"key":"8036_CR35","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/01.STR.0000227259.15506.24","volume":"37","author":"T Tsubokawa","year":"2006","unstructured":"Tsubokawa T (2006) Cathepsin and calpain inhibitor E64d attenuates matrix metvalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke 37:1888\u20131894","journal-title":"Stroke"},{"key":"8036_CR36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jnr.20977","volume":"84","author":"T Tsubokawa","year":"2006","unstructured":"Tsubokawa T (2006) Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats. J Neurosci Res 84:832\u2013840","journal-title":"J Neurosci Res"},{"key":"8036_CR37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/978-1-4020-6191-2_17","volume":"45","author":"A Verkhratsky","year":"2007","unstructured":"Verkhratsky A (2007) Calcium and cell death. Subcell Biochem 45:465\u2013480","journal-title":"Subcell Biochem"},{"key":"8036_CR38","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1471-4159.2006.04063.x","volume":"98","author":"WJ Pottorf 2nd","year":"2006","unstructured":"Pottorf WJ 2nd (2006) Glutamate-induced protease-mediated loss of plasma membrane Ca2+ pump activity in rat hippocampal neurons. J Neurochem 98:1646\u20131656","journal-title":"J Neurochem"},{"key":"8036_CR39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2004.11.049","volume":"120","author":"D Bano","year":"2005","unstructured":"Bano D (2005) Cleavage of the plasma membrane Na+\/Ca2+ exchanger in excitotoxicity. Cell 120:275\u2013285","journal-title":"Cell"},{"key":"8036_CR40","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1046\/j.1471-4159.1994.63041558.x","volume":"63","author":"KS Jongh De","year":"1994","unstructured":"De Jongh KS (1994) Differential proteolysis of the full-length form of the L-type calcium channel alpha 1 subunit by calpain. J Neurochem 63:1558\u20131564","journal-title":"J Neurochem"},{"key":"8036_CR41","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1073\/pnas.93.8.3362","volume":"93","author":"JW Hell","year":"1996","unstructured":"Hell JW (1996) N-methyl-D-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons. Proc Natl Acad Sci U S A 93:3362\u20133367","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.RES.67.1.84","volume":"67","author":"DP Rardon","year":"1990","unstructured":"Rardon DP (1990) Digestion of cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles with calpain II. Effects on the Ca2+ release channel. Circ Res 67:84\u201396","journal-title":"Circ Res"},{"key":"8036_CR43","doi-asserted-by":"crossref","first-page":"H128","DOI":"10.1152\/ajpheart.00739.2005","volume":"290","author":"JP French","year":"2006","unstructured":"French JP (2006) Ischemia\u2013reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition. Am J Physiol Heart Circ Physiol 290:H128\u2013H136","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"8036_CR44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(99)01504-8","volume":"834","author":"JT Parsons","year":"1999","unstructured":"Parsons JT (1999) Global ischemia-induced inhibition of the coupling ratio of calcium uptake and ATP hydrolysis by rat whole brain microsomal Mg(2+)\/Ca(2+) ATPase. Brain Res 834:32\u201341","journal-title":"Brain Res"},{"key":"8036_CR45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-5793(93)81345-Z","volume":"323","author":"A Magnusson","year":"1993","unstructured":"Magnusson A (1993) Calcium-induced degradation of the inositol (1,4,5)-trisphosphate receptor\/Ca(2+)-channel. FEBS Lett 323:229\u2013232","journal-title":"FEBS Lett"},{"key":"8036_CR46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/bj20030505","volume":"375","author":"K Pattni","year":"2003","unstructured":"Pattni K (2003) Calpain cleavage of the B isoform of Ins(1,4,5)P3 3-kinase separates the catalytic domain from the membrane anchoring domain. Biochem J 375:643\u2013651","journal-title":"Biochem J"},{"key":"8036_CR47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.mp.4002017","volume":"13","author":"S Gascon","year":"2008","unstructured":"Gascon S (2008) Excitotoxicity and focal cerebral ischemia induce truncation of the NR2A and NR2B subunits of the NMDA receptor and cleavage of the scaffolding protein PSD-95. Mol Psychiatry 13:99\u2013114","journal-title":"Mol Psychiatry"},{"key":"8036_CR48","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1046\/j.1471-4159.2001.00493.x","volume":"78","author":"RP Guttmann","year":"2001","unstructured":"Guttmann RP (2001) Specific proteolysis of the NR2 subunit at multiple sites by calpain. J Neurochem 78:1083\u20131093","journal-title":"J Neurochem"},{"key":"8036_CR49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.102.036962","volume":"302","author":"RP Guttmann","year":"2002","unstructured":"Guttmann RP (2002) Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J Pharmacol Exp Ther 302:1023\u20131030","journal-title":"J Pharmacol Exp Ther"},{"key":"8036_CR50","doi-asserted-by":"crossref","first-page":"11322","DOI":"10.1523\/JNEUROSCI.23-36-11322.2003","volume":"23","author":"KL Simpkins","year":"2003","unstructured":"Simpkins KL (2003) Selective activation induced cleavage of the NR2B subunit by calpain. J Neurosci 23:11322\u201311331","journal-title":"J Neurosci"},{"key":"8036_CR51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0006-8993(98)00433-8","volume":"797","author":"R Bi","year":"1998","unstructured":"Bi R (1998) Phosphorylation regulates calpain-mediated truncation of glutamate ionotropic receptors. Brain Res 797:154\u2013158","journal-title":"Brain Res"},{"key":"8036_CR52","first-page":"203","volume":"144","author":"X Bi","year":"2000","unstructured":"Bi X (2000) Calpain-mediated truncation of glutamate ionotropic receptors. Methods for studying the effects of calpain activation in brain tissue. Methods Mol Biol 144:203\u2013217","journal-title":"Methods Mol Biol"},{"key":"8036_CR53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0006-8993(97)01365-6","volume":"781","author":"X Bi","year":"1998","unstructured":"Bi X (1998) Calpain-mediated proteolysis of GluR1 subunits in organotypic hippocampal cultures following kainic acid treatment. Brain Res 781:355\u2013357","journal-title":"Brain Res"},{"key":"8036_CR54","doi-asserted-by":"crossref","first-page":"21588","DOI":"10.1074\/jbc.M501603200","volume":"280","author":"HY Wu","year":"2005","unstructured":"Wu HY (2005) Regulation of N-methyl-D-aspartate receptors by calpain in cortical neurons. J Biol Chem 280:21588\u201321593","journal-title":"J Biol Chem"},{"key":"8036_CR55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2006.12.020","volume":"53","author":"W Xu","year":"2007","unstructured":"Xu W (2007) Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity. Neuron 53:399\u2013412","journal-title":"Neuron"},{"key":"8036_CR56","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1074\/jbc.M410591200","volume":"280","author":"B Tremper-Wells","year":"2005","unstructured":"Tremper-Wells B (2005) Nuclear calpain regulates Ca2+-dependent signaling via proteolysis of nuclear Ca2+\/calmodulin-dependent protein kinase type IV in cultured neurons. J Biol Chem 280:2165\u20132175","journal-title":"J Biol Chem"},{"key":"8036_CR57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/371336a0","volume":"371","author":"J Sharkey","year":"1994","unstructured":"Sharkey J (1994) Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371:336\u2013339","journal-title":"Nature"},{"key":"8036_CR58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/nbdi.2002.0514","volume":"10","author":"H Uchino","year":"2002","unstructured":"Uchino H (2002) Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol Dis 10:219\u2013233","journal-title":"Neurobiol Dis"},{"key":"8036_CR59","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1471-4159.2007.04600.x","volume":"102","author":"N Shioda","year":"2007","unstructured":"Shioda N (2007) Constitutively active calcineurin mediates delayed neuronal death through Fas-ligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia. J Neurochem 102:1506\u20131517","journal-title":"J Neurochem"},{"key":"8036_CR60","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2006.03874.x","volume":"98","author":"N Shioda","year":"2006","unstructured":"Shioda N (2006) Generation of constitutively active calcineurin by calpain contributes to delayed neuronal death following mouse brain ischemia. J Neurochem 98:310\u2013320","journal-title":"J Neurochem"},{"key":"8036_CR61","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/00004647-199808000-00007","volume":"18","author":"RW Neumar","year":"1998","unstructured":"Neumar RW (1998) Calpain mediates eukaryotic initiation factor 4G degradation during global brain ischemia. J Cereb Blood Flow Metab 18:876\u2013881","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"8036_CR62","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/BJ20071060","volume":"411","author":"V Petegnief","year":"2008","unstructured":"Petegnief V (2008) Nitric oxide mediates NMDA-induced persistent inhibition of protein synthesis through dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 and eukaryotic initiation factor 4G proteolysis. Biochem J 411(3):667\u2013677","journal-title":"Biochem J"},{"key":"8036_CR63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0378-1119(99)00357-1","volume":"238","author":"G Suske","year":"1999","unstructured":"Suske G (1999) The Sp-family of transcription factors. Gene 238:291\u2013300","journal-title":"Gene"},{"key":"8036_CR64","doi-asserted-by":"crossref","first-page":"44911","DOI":"10.1074\/jbc.M204292200","volume":"277","author":"X Mao","year":"2002","unstructured":"Mao X (2002) Neuronal kappa B-binding factors consist of Sp1-related proteins. Functional implications for autoregulation of N-methyl-D-aspartate receptor-1 expression. J Biol Chem 277:44911\u201344919","journal-title":"J Biol Chem"},{"key":"8036_CR65","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1471-4159.2006.04297.x","volume":"100","author":"X Mao","year":"2007","unstructured":"Mao X (2007) Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons. J Neurochem 100:1300\u20131314","journal-title":"J Neurochem"},{"key":"8036_CR66","doi-asserted-by":"crossref","first-page":"35018","DOI":"10.1074\/jbc.M504108200","volume":"280","author":"S Gascon","year":"2005","unstructured":"Gascon S (2005) Transcription of the NR1 subunit of the N-methyl-D-aspartate receptor is down-regulated by excitotoxic stimulation and cerebral ischemia. J Biol Chem 280:35018\u201335027","journal-title":"J Biol Chem"},{"key":"8036_CR67","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1523\/JNEUROSCI.4485-05.2006","volume":"26","author":"ST Hou","year":"2006","unstructured":"Hou ST (2006) Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia. J Neurosci 26:2241\u20132249","journal-title":"J Neurosci"},{"key":"8036_CR68","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1460-9568.2007.05715.x","volume":"26","author":"SX Jiang","year":"2007","unstructured":"Jiang SX (2007) Calpain cleavage of collapsin response mediator proteins in ischemic mouse brain. Eur J Neurosci 26:801\u2013809","journal-title":"Eur J Neurosci"},{"key":"8036_CR69","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1471-4159.2006.03969.x","volume":"98","author":"S Bretin","year":"2006","unstructured":"Bretin S (2006) Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J Neurochem 98:1252\u20131265","journal-title":"J Neurochem"},{"key":"8036_CR70","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1073\/pnas.0500099102","volume":"102","author":"J Rashidian","year":"2005","unstructured":"Rashidian J (2005) Multiple cyclin-dependent kinases signals are critical mediators of ischemia\/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci U S A 102:14080\u201314085","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR71","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbadis.2006.10.011","volume":"1772","author":"Y Wen","year":"2007","unstructured":"Wen Y (2007) Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 1772:473\u2013483","journal-title":"Biochim Biophys Acta"},{"key":"8036_CR72","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913\u20134917","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR73","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8036_CR74","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/156720508783954749","volume":"5","author":"B Vincent","year":"2008","unstructured":"Vincent B (2008) Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives. Curr Alzheimer Res 5:202\u2013211","journal-title":"Curr Alzheimer Res"},{"key":"8036_CR75","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue LF (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am J Pathol 155:853\u2013862","journal-title":"Am J Pathol"},{"key":"8036_CR76","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","volume":"283","author":"J Naslund","year":"2000","unstructured":"Naslund J (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283:1571\u20131577","journal-title":"JAMA"},{"key":"8036_CR77","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FG Felice De","year":"2007","unstructured":"De Felice FG (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590\u201311601","journal-title":"J Biol Chem"},{"key":"8036_CR78","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","volume":"280","author":"A Demuro","year":"2005","unstructured":"Demuro A (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280:17294\u201317300","journal-title":"J Biol Chem"},{"key":"8036_CR79","doi-asserted-by":"crossref","first-page":"28079","DOI":"10.1074\/jbc.M605081200","volume":"281","author":"BL Kelly","year":"2006","unstructured":"Kelly BL (2006) Beta-amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem 281:28079\u201328089","journal-title":"J Biol Chem"},{"key":"8036_CR80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.1994.tb44402.x","volume":"747","author":"RA Nixon","year":"1994","unstructured":"Nixon RA (1994) Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer\u2019s disease. Ann N Y Acad Sci 747:77\u201391","journal-title":"Ann N Y Acad Sci"},{"key":"8036_CR81","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1073\/pnas.90.7.2628","volume":"90","author":"K Saito","year":"1993","unstructured":"Saito K (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90:2628\u20132632","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR82","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0002-9440(10)63342-1","volume":"165","author":"Veeranna","year":"2004","unstructured":"Veeranna (2004) Calpain mediates calcium-induced activation of the Erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer\u2019s disease. Am J Pathol 165:795\u2013805","journal-title":"Am J Pathol"},{"key":"8036_CR83","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbrc.2004.02.052","volume":"316","author":"M Chen","year":"2004","unstructured":"Chen M (2004) Stimulation of beta-amyloid precursor protein alpha-processing by phorbol ester involves calcium and calpain activation. Biochem Biophys Res Commun 316:332\u2013340","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR84","doi-asserted-by":"crossref","first-page":"14140","DOI":"10.1074\/jbc.270.23.14140","volume":"270","author":"QX Li","year":"1995","unstructured":"Li QX (1995) Proteolytic processing of Alzheimer\u2019s disease beta A4 amyloid precursor protein in human platelets. J Biol Chem 270:14140\u201314147","journal-title":"J Biol Chem"},{"key":"8036_CR85","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1523\/JNEUROSCI.10-07-02400.1990","volume":"10","author":"R Siman","year":"1990","unstructured":"Siman R (1990) Proteolytic processing of beta-amyloid precursor by calpain I. J Neurosci 10:2400\u20132411","journal-title":"J Neurosci"},{"key":"8036_CR86","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbrc.2005.03.029","volume":"330","author":"M Chen","year":"2005","unstructured":"Chen M (2005) Mu-calpain is functionally required for alpha-processing of Alzheimer\u2019s beta-amyloid precursor protein. Biochem Biophys Res Commun 330:714\u2013721","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR87","doi-asserted-by":"crossref","first-page":"31746","DOI":"10.1074\/jbc.M503259200","volume":"280","author":"BL Kelly","year":"2005","unstructured":"Kelly BL (2005) Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease. J Biol Chem 280:31746\u201331753","journal-title":"J Biol Chem"},{"key":"8036_CR88","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S (2003) Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409\u2013421","journal-title":"Neuron"},{"key":"8036_CR89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbrc.2005.02.121","volume":"330","author":"PJ Yao","year":"2005","unstructured":"Yao PJ (2005) Preserved synaptic vesicle recycling in hippocampal neurons in a mouse Alzheimer\u2019s disease model. Biochem Biophys Res Commun 330:34\u201338","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR90","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0092-8674(02)00657-8","volume":"108","author":"A Barco","year":"2002","unstructured":"Barco A (2002) Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 108:689\u2013703","journal-title":"Cell"},{"key":"8036_CR91","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1471-4159.2007.04942.x","volume":"103","author":"Z Liang","year":"2007","unstructured":"Liang Z (2007) Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J Neurochem 103:2462\u20132470","journal-title":"J Neurochem"},{"key":"8036_CR92","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/MCB.22.8.2716-2727.2002","volume":"22","author":"H Shiraha","year":"2002","unstructured":"Shiraha H (2002) Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol 22:2716\u20132727","journal-title":"Mol Cell Biol"},{"key":"8036_CR93","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1023\/B:NERE.0000042218.27842.79","volume":"29","author":"A Lakshmikuttyamma","year":"2004","unstructured":"Lakshmikuttyamma A (2004) In vitro proteolytic degradation of bovine brain calcineurin by m-calpain. Neurochem Res 29:1913\u20131921","journal-title":"Neurochem Res"},{"key":"8036_CR94","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1139\/o89-105","volume":"67","author":"KK Wang","year":"1989","unstructured":"Wang KK (1989) Characterization of the fragmented forms of calcineurin produced by calpain I. Biochem Cell Biol 67:703\u2013711","journal-title":"Biochem Cell Biol"},{"key":"8036_CR95","doi-asserted-by":"crossref","first-page":"37755","DOI":"10.1074\/jbc.M507475200","volume":"280","author":"F Liu","year":"2005","unstructured":"Liu F (2005) Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 280:37755\u201337762","journal-title":"J Biol Chem"},{"key":"8036_CR96","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.bi.58.070189.002321","volume":"58","author":"P Cohen","year":"1989","unstructured":"Cohen P (1989) The structure and regulation of protein phosphatases. Annu Rev Biochem 58:453\u2013508","journal-title":"Annu Rev Biochem"},{"key":"8036_CR97","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1196\/annals.1299.115","volume":"1010","author":"P Delobel","year":"2003","unstructured":"Delobel P (2003) Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies. Ann N Y Acad Sci 1010:623\u2013634","journal-title":"Ann N Y Acad Sci"},{"key":"8036_CR98","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.emboj.7600441","volume":"24","author":"YL Zheng","year":"2005","unstructured":"Zheng YL (2005) A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. Embo J 24:209\u2013220","journal-title":"Embo J"},{"key":"8036_CR99","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1016\/S0021-9258(19)84966-9","volume":"264","author":"A Kishimoto","year":"1989","unstructured":"Kishimoto A (1989) Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem 264:4088\u20134092","journal-title":"J Biol Chem"},{"key":"8036_CR100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/oxfordjournals.jbchem.a021234","volume":"119","author":"Y Yoshimura","year":"1996","unstructured":"Yoshimura Y (1996) Purification and characterization of active fragment of Ca2+\/calmodulin-dependent protein kinase II from the post-synaptic density in the rat forebrain. J Biochem 119:268\u2013273","journal-title":"J Biochem"},{"key":"8036_CR101","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1046\/j.1471-4159.1996.66041539.x","volume":"66","author":"TB Shea","year":"1996","unstructured":"Shea TB (1996) Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: involvement of calpain-mediated hydrolysis of protein kinase C. J Neurochem 66:1539\u20131549","journal-title":"J Neurochem"},{"key":"8036_CR102","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","volume":"20","author":"JJ Lucas","year":"2001","unstructured":"Lucas JJ (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. Embo J 20:27\u201339","journal-title":"Embo J"},{"key":"8036_CR103","doi-asserted-by":"crossref","first-page":"22406","DOI":"10.1074\/jbc.M702793200","volume":"282","author":"P Goni-Oliver","year":"2007","unstructured":"Goni-Oliver P (2007) N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation. J Biol Chem 282:22406\u201322413","journal-title":"J Biol Chem"},{"key":"8036_CR104","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00018-007-7045-7","volume":"64","author":"JE Forde","year":"2007","unstructured":"Forde JE (2007) Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 64:1930\u20131944","journal-title":"Cell Mol Life Sci"},{"key":"8036_CR105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuron.2007.01.016","volume":"53","author":"K Abe","year":"2007","unstructured":"Abe K (2007) NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression. Neuron 53:387\u2013397","journal-title":"Neuron"},{"key":"8036_CR106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2004.11.005","volume":"49","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ (2005) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer\u2019s disease. Brain Res Brain Res Rev 49:1\u201321","journal-title":"Brain Res Brain Res Rev"},{"key":"8036_CR107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gde.2006.12.007","volume":"17","author":"P Polakis","year":"2007","unstructured":"Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45\u201351","journal-title":"Curr Opin Genet Dev"},{"key":"8036_CR108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2003.12.117","volume":"361","author":"ZH Cheung","year":"2004","unstructured":"Cheung ZH (2004) Cdk5: mediator of neuronal death and survival. Neurosci Lett 361:47\u201351","journal-title":"Neurosci Lett"},{"key":"8036_CR109","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1567205043480519","volume":"1","author":"EA Monaco 3rd","year":"2004","unstructured":"Monaco EA 3rd (2004) Recent evidence regarding a role for Cdk5 dysregulation in Alzheimer\u2019s disease. Curr Alzheimer Res 1:33\u201338","journal-title":"Curr Alzheimer Res"},{"key":"8036_CR110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/371419a0","volume":"371","author":"LH Tsai","year":"1994","unstructured":"Tsai LH (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419\u2013423","journal-title":"Nature"},{"key":"8036_CR111","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbrc.2006.04.032","volume":"345","author":"A Jamsa","year":"2006","unstructured":"Jamsa A (2006) Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells. Biochem Biophys Res Commun 345:324\u2013331","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR112","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","volume":"402","author":"GN Patrick","year":"1999","unstructured":"Patrick GN (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615\u2013622","journal-title":"Nature"},{"key":"8036_CR113","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0014-5793(99)01279-X","volume":"459","author":"A Alvarez","year":"1999","unstructured":"Alvarez A (1999) Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death. FEBS Lett 459:421\u2013426","journal-title":"FEBS Lett"},{"key":"8036_CR114","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","volume":"405","author":"MS Lee","year":"2000","unstructured":"Lee MS (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360\u2013364","journal-title":"Nature"},{"key":"8036_CR115","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10571-007-9224-3","volume":"27","author":"JP Lopes","year":"2007","unstructured":"Lopes JP (2007) Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-beta and prion peptides: implications for Alzheimer\u2019s disease and prion-related encephalopathies. Cell Mol Neurobiol 27:943\u2013957","journal-title":"Cell Mol Neurobiol"},{"key":"8036_CR116","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-4159.2007.04540.x","volume":"102","author":"T Saito","year":"2007","unstructured":"Saito T (2007) p25\/cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons. J Neurochem 102:133\u2013140","journal-title":"J Neurochem"},{"key":"8036_CR117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2003.12.005","volume":"72","author":"EB Becker","year":"2004","unstructured":"Becker EB (2004) Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol 72:1\u201325","journal-title":"Prog Neurobiol"},{"key":"8036_CR118","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1044-7431(03)00221-5","volume":"24","author":"JH Weishaupt","year":"2003","unstructured":"Weishaupt JH (2003) Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction. Mol Cell Neurosci 24:489\u2013502","journal-title":"Mol Cell Neurosci"},{"key":"8036_CR119","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1062382","volume":"293","author":"CW Wittmann","year":"2001","unstructured":"Wittmann CW (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293:711\u2013714","journal-title":"Science"},{"key":"8036_CR120","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1523\/JNEUROSCI.23-33-10662.2003","volume":"23","author":"Y Yoshiyama","year":"2003","unstructured":"Yoshiyama Y (2003) Reduction of detyrosinated microtubules and Golgi fragmentation are linked to tau-induced degeneration in astrocytes. J Neurosci 23:10662\u201310671","journal-title":"J Neurosci"},{"key":"8036_CR121","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1523\/JNEUROSCI.1125-05.2005","volume":"25","author":"SY Park","year":"2005","unstructured":"Park SY (2005) The generation of a 17\u00a0kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25:5365\u20135375","journal-title":"J Neurosci"},{"key":"8036_CR122","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0511065103","volume":"103","author":"G Amadoro","year":"2006","unstructured":"Amadoro G (2006) NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation. Proc Natl Acad Sci U S A 103:2892\u20132897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","volume":"991","author":"S Fahn","year":"2003","unstructured":"Fahn S (2003) Description of Parkinson\u2019s disease as a clinical syndrome. Ann N Y Acad Sci 991:1\u201314","journal-title":"Ann N Y Acad Sci"},{"key":"8036_CR124","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","volume":"7","author":"MJ Farrer","year":"2006","unstructured":"Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306\u2013318","journal-title":"Nat Rev Genet"},{"issue":"7","key":"8036_CR125","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1742-4658.2008.06301.x","volume":"275","author":"AC Belin","year":"2008","unstructured":"Belin AC (2008) Parkinson\u2019s disease: a genetic perspective. Febs J 275(7):1377\u20131383","journal-title":"Febs J"},{"issue":"Suppl","key":"8036_CR126","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1002\/ana.410320715","volume":"32","author":"EC Hirsch","year":"1992","unstructured":"Hirsch EC (1992) Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson\u2019s disease? Ann Neurol 32(Suppl):S88\u2013S93","journal-title":"Ann Neurol"},{"key":"8036_CR127","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.87.11.4078","volume":"87","author":"AM Iacopino","year":"1990","unstructured":"Iacopino AM (1990) Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci U S A 87:4078\u20134082","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-8993(94)90511-8","volume":"668","author":"A Mouatt-Prigent","year":"1994","unstructured":"Mouatt-Prigent A (1994) Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson\u2019s disease? Brain Res 668:62\u201370","journal-title":"Brain Res"},{"key":"8036_CR129","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0306-4522(96)00100-5","volume":"73","author":"A Mouatt-Prigent","year":"1996","unstructured":"Mouatt-Prigent A (1996) Increased m-calpain expression in the mesencephalon of patients with Parkinson\u2019s disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 73:979\u2013987","journal-title":"Neuroscience"},{"key":"8036_CR130","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1021\/bi00107a008","volume":"30","author":"K Kiuchi","year":"1991","unstructured":"Kiuchi K (1991) Limited proteolysis of tyrosine hydroxylase by Ca(2+)-activated neutral protease (calpain). Biochemistry 30:10416\u201310419","journal-title":"Biochemistry"},{"key":"8036_CR131","doi-asserted-by":"crossref","unstructured":"Barzilai A (2000) The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity. J Neural Transm Suppl 59\u201376","DOI":"10.1007\/978-3-7091-6301-6_4"},{"key":"8036_CR132","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","volume":"9","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ (2000) Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum Mol Genet 9:2683\u20132689","journal-title":"Hum Mol Genet"},{"key":"8036_CR133","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2006.04146.x","volume":"99","author":"R Tehranian","year":"2006","unstructured":"Tehranian R (2006) Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells. J Neurochem 99:1188\u20131196","journal-title":"J Neurochem"},{"key":"8036_CR134","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-9861(20000403)419:2<175::AID-CNE3>3.0.CO;2-2","volume":"419","author":"A Mouatt-Prigent","year":"2000","unstructured":"Mouatt-Prigent A (2000) Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson\u2019s disease. J Comp Neurol 419:175\u2013192","journal-title":"J Comp Neurol"},{"key":"8036_CR135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.6403987","volume":"220","author":"G Kolata","year":"1983","unstructured":"Kolata G (1983) Monkey model of Parkinson\u2019s disease. Science 220:705","journal-title":"Science"},{"key":"8036_CR136","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979\u2013980","journal-title":"Science"},{"key":"8036_CR137","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","volume":"120","author":"K Chiba","year":"1984","unstructured":"Chiba K (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120:574\u2013578","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR138","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/bss0660085","volume":"66","author":"JT Greenamyre","year":"1999","unstructured":"Greenamyre JT (1999) Mitochondrial dysfunction in Parkinson\u2019s disease. Biochem Soc Symp 66:85\u201397","journal-title":"Biochem Soc Symp"},{"key":"8036_CR139","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"DC Wu","year":"2003","unstructured":"Wu DC (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 100:6145\u2013650","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01271538","volume":"100","author":"TS Chen","year":"1995","unstructured":"Chen TS (1995) MPP+ selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57\/Bl6 mice. J Neural Transm Gen Sect 100:153\u2013163","journal-title":"J Neural Transm Gen Sect"},{"key":"8036_CR141","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1523\/JNEUROSCI.23-10-04081.2003","volume":"23","author":"SJ Crocker","year":"2003","unstructured":"Crocker SJ (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson\u2019s disease. J Neurosci 23:4081\u20134091","journal-title":"J Neurosci"},{"key":"8036_CR142","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1073\/pnas.95.19.11462","volume":"95","author":"JM Radke","year":"1998","unstructured":"Radke JM (1998) Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions. Proc Natl Acad Sci U S A 95:11462\u201311464","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR143","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/syn.1093","volume":"41","author":"A Martorana","year":"2001","unstructured":"Martorana A (2001) Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons. Synapse 41:360\u2013362","journal-title":"Synapse"},{"key":"8036_CR144","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp.70.6.784","volume":"70","author":"RM Schimpff","year":"2001","unstructured":"Schimpff RM (2001) Increased plasma neurotensin concentrations in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 70:784\u2013786","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8036_CR145","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1096\/fj.04-3258fje","volume":"19","author":"AK Liou","year":"2005","unstructured":"Liou AK (2005) BimEL up-regulation potentiates AIF translocation and cell death in response to MPTP. Faseb J 19:1350\u20131352","journal-title":"Faseb J"},{"key":"8036_CR146","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1523\/JNEUROSCI.2826-07.2007","volume":"27","author":"G Cao","year":"2007","unstructured":"Cao G (2007) Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J Neurosci 27:9278\u20139293","journal-title":"J Neurosci"},{"key":"8036_CR147","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1471-4159.2003.01878.x","volume":"86","author":"AJ Mishizen-Eberz","year":"2003","unstructured":"Mishizen-Eberz AJ (2003) Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro. J Neurochem 86:836\u201347","journal-title":"J Neurochem"},{"key":"8036_CR148","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1021\/bi047846q","volume":"44","author":"AJ Mishizen-Eberz","year":"2005","unstructured":"Mishizen-Eberz AJ (2005) Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry 44:7818\u20137829","journal-title":"Biochemistry"},{"key":"8036_CR149","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"102","author":"W Li","year":"2005","unstructured":"Li W (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc Natl Acad Sci U S A 102:2162\u20132167","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR150","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","volume":"170","author":"BM Dufty","year":"2007","unstructured":"Dufty BM (2007) Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. Am J Pathol 170:1725\u20131738","journal-title":"Am J Pathol"},{"key":"8036_CR151","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","volume":"26","author":"GK Tofaris","year":"2006","unstructured":"Tofaris GK (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1\u2013120): implications for Lewy body disorders. J Neurosci 26:3942\u20133950","journal-title":"J Neurosci"},{"key":"8036_CR152","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","volume":"25","author":"H Shimura","year":"2000","unstructured":"Shimura H (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25:302\u2013305","journal-title":"Nat Genet"},{"key":"8036_CR153","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","volume":"97","author":"Y Zhang","year":"2000","unstructured":"Zhang Y (2000) Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A 97:13354\u201313359","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR154","doi-asserted-by":"crossref","first-page":"41890","DOI":"10.1074\/jbc.M306017200","volume":"278","author":"SJ Kim","year":"2003","unstructured":"Kim SJ (2003) Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain. J Biol Chem 278:41890\u201341899","journal-title":"J Biol Chem"},{"key":"8036_CR155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2005.12.011","volume":"397","author":"MJ Chen","year":"2006","unstructured":"Chen MJ (2006) Early induction of calpains in rotenone-mediated neuronal apoptosis. Neurosci Lett 397:69\u201373","journal-title":"Neurosci Lett"},{"key":"8036_CR156","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0896-6273(04)00017-0","volume":"41","author":"II Kruman","year":"2004","unstructured":"Kruman II (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41:549\u2013561","journal-title":"Neuron"},{"key":"8036_CR157","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1074\/jbc.M302833200","volume":"278","author":"M Sedarous","year":"2003","unstructured":"Sedarous M (2003) Calpains mediate p53 activation and neuronal death evoked by DNA damage. J Biol Chem 278:26031\u201326038","journal-title":"J Biol Chem"},{"key":"8036_CR158","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/MCB.17.1.460","volume":"17","author":"MH Kubbutat","year":"1997","unstructured":"Kubbutat MH (1997) Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 17:460\u2013468","journal-title":"Mol Cell Biol"},{"key":"8036_CR159","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuroscience.2007.01.056","volume":"146","author":"S Samantaray","year":"2007","unstructured":"Samantaray S (2007) The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 146:741\u2013755","journal-title":"Neuroscience"},{"key":"8036_CR160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1369.034","volume":"1074","author":"S Samantaray","year":"2006","unstructured":"Samantaray S (2006) Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism. Ann N Y Acad Sci 1074:349\u2013356","journal-title":"Ann N Y Acad Sci"},{"key":"8036_CR161","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","volume":"249","author":"G Cohen","year":"1974","unstructured":"Cohen G (1974) The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 249:2447\u20132452","journal-title":"J Biol Chem"},{"key":"8036_CR162","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.freeradbiomed.2006.12.004","volume":"42","author":"Y Saito","year":"2007","unstructured":"Saito Y (2007) Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Radic Biol Med 42:675\u2013685","journal-title":"Free Radic Biol Med"},{"key":"8036_CR163","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80015-U","volume":"287","author":"S Hirai","year":"1991","unstructured":"Hirai S (1991) Degradation of transcription factors, c-Jun and c-Fos, by calpain. FEBS Lett 287:57\u201361","journal-title":"FEBS Lett"},{"key":"8036_CR164","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1073\/pnas.181182298","volume":"98","author":"XG Xia","year":"2001","unstructured":"Xia XG (2001) Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 98:10433\u201310438","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuron.2007.05.033","volume":"55","author":"D Qu","year":"2007","unstructured":"Qu D (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson\u2019s disease. Neuron 55:37\u201352","journal-title":"Neuron"},{"key":"8036_CR166","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.2875-05.2006","volume":"26","author":"PD Smith","year":"2006","unstructured":"Smith PD (2006) Calpain-regulated p35\/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci 26:440\u2013447","journal-title":"J Neurosci"},{"key":"8036_CR167","doi-asserted-by":"crossref","first-page":"12842","DOI":"10.1074\/jbc.M608243200","volume":"282","author":"E Avraham","year":"2007","unstructured":"Avraham E (2007) Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J Biol Chem 282:12842\u201312850","journal-title":"J Biol Chem"},{"issue":"4","key":"8036_CR168","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.parkreldis.2007.09.005","volume":"14","author":"D Alvira","year":"2007","unstructured":"Alvira D (2007) Activation of the calpain\/cdk5\/p25 pathway in the girus cinguli in Parkinson\u2019s disease. Parkinsonism Relat Disord 14(4):309\u2013313","journal-title":"Parkinsonism Relat Disord"},{"key":"8036_CR169","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-079X.2005.00308.x","volume":"40","author":"D Alvira","year":"2006","unstructured":"Alvira D (2006) Inhibition of the cdk5\/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson\u2019s disease. J Pineal Res 40:251\u2013258","journal-title":"J Pineal Res"},{"key":"8036_CR170","doi-asserted-by":"crossref","unstructured":"(1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72:971\u2013983","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"8036_CR171","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1172\/JCI17742","volume":"111","author":"AB Young","year":"2003","unstructured":"Young AB (2003) Huntingtin in health and disease. J Clin Invest 111:299\u2013302","journal-title":"J Clin Invest"},{"key":"8036_CR172","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","volume":"230","author":"RJ Ferrante","year":"1985","unstructured":"Ferrante RJ (1985) Selective sparing of a class of striatal neurons in Huntington\u2019s disease. Science 230:561\u2013563","journal-title":"Science"},{"key":"8036_CR173","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410270217","volume":"27","author":"M Cudkowicz","year":"1990","unstructured":"Cudkowicz M (1990) Degeneration of pyramidal projection neurons in Huntington\u2019s disease cortex. Ann Neurol 27:200\u2013204","journal-title":"Ann Neurol"},{"key":"8036_CR174","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","volume":"70","author":"E Brouillet","year":"1998","unstructured":"Brouillet E (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794\u2013805","journal-title":"J Neurochem"},{"key":"8036_CR175","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","volume":"92","author":"E Brouillet","year":"1995","unstructured":"Brouillet E (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci U S A 92:7105\u20137109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR176","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39:385\u2013389","journal-title":"Ann Neurol"},{"key":"8036_CR177","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"8036_CR178","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-005-3454-9","volume":"269","author":"AV Panov","year":"2005","unstructured":"Panov AV (2005) Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington\u2019s disease individuals. Mol Cell Biochem 269:143\u2013152","journal-title":"Mol Cell Biochem"},{"key":"8036_CR179","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"8036_CR180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/78054","volume":"25","author":"H Li","year":"2000","unstructured":"Li H (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet 25:385\u2013389","journal-title":"Nat Genet"},{"key":"8036_CR181","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","volume":"72","author":"N Chen","year":"1999","unstructured":"Chen N (1999) Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J Neurochem 72:1890\u20131898","journal-title":"J Neurochem"},{"key":"8036_CR182","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","volume":"17","author":"MM Zeron","year":"2001","unstructured":"Zeron MM (2001) Mutant huntingtin enhances excitotoxic cell death. Mol Cell Neurosci 17:41\u201353","journal-title":"Mol Cell Neurosci"},{"key":"8036_CR183","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","volume":"33","author":"MM Zeron","year":"2002","unstructured":"Zeron MM (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease. Neuron 33:849\u2013860","journal-title":"Neuron"},{"key":"8036_CR184","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","volume":"27","author":"HB Fernandes","year":"2007","unstructured":"Fernandes HB (2007) Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington\u2019s disease. J Neurosci 27:13614\u201313623","journal-title":"J Neurosci"},{"key":"8036_CR185","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1523\/JNEUROSCI.23-12-04858.2003","volume":"23","author":"N Brustovetsky","year":"2003","unstructured":"Brustovetsky N (2003) Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J Neurosci 23:4858\u20134867","journal-title":"J Neurosci"},{"key":"8036_CR186","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","volume":"93","author":"N Brustovetsky","year":"2005","unstructured":"Brustovetsky N (2005) Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington\u2019s disease. J Neurochem 93:1361\u20131370","journal-title":"J Neurochem"},{"key":"8036_CR187","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.nbd.2003.09.013","volume":"15","author":"MC Galas","year":"2004","unstructured":"Galas MC (2004) Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms. Neurobiol Dis 15:152\u2013159","journal-title":"Neurobiol Dis"},{"key":"8036_CR188","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1096\/fj.05-5085fje","volume":"20","author":"C Jacquard","year":"2006","unstructured":"Jacquard C (2006) Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation. Faseb J 20:1021\u20131023","journal-title":"Faseb J"},{"key":"8036_CR189","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"8036_CR190","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","volume":"42","author":"E Sapp","year":"1997","unstructured":"Sapp E (1997) Huntingtin localization in brains of normal and Huntington\u2019s disease patients. Ann Neurol 42:604\u2013612","journal-title":"Ann Neurol"},{"key":"8036_CR191","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"8036_CR192","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","volume":"90","author":"E Scherzinger","year":"1997","unstructured":"Scherzinger E (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90:549\u201358","journal-title":"Cell"},{"key":"8036_CR193","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","volume":"13","author":"YP Goldberg","year":"1996","unstructured":"Goldberg YP (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 13:442\u2013449","journal-title":"Nat Genet"},{"key":"8036_CR194","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","volume":"273","author":"CL Wellington","year":"1998","unstructured":"Wellington CL (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158\u20139167","journal-title":"J Biol Chem"},{"key":"8036_CR195","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim YJ (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington\u2019s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci U S A 98:12784\u201312789","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR196","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni J (2002) Calpain activation in Huntington\u2019s disease. J Neurosci 22:4842\u20134849","journal-title":"J Neurosci"},{"key":"8036_CR197","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/nbdi.2002.0539","volume":"11","author":"B Sun","year":"2002","unstructured":"Sun B (2002) Polyglutamine repeat length-dependent proteolysis of huntingtin. Neurobiol Dis 11:111\u2013122","journal-title":"Neurobiol Dis"},{"key":"8036_CR198","doi-asserted-by":"crossref","first-page":"39594","DOI":"10.1074\/jbc.C200353200","volume":"277","author":"D Goffredo","year":"2002","unstructured":"Goffredo D (2002) Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J Biol Chem 277:39594\u201339598","journal-title":"J Biol Chem"},{"key":"8036_CR199","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1083\/jcb.141.5.1097","volume":"141","author":"AS Hackam","year":"1998","unstructured":"Hackam AS (1998) The influence of huntingtin protein size on nuclear localization and cellular toxicity. J Cell Biol 141:1097\u20131105","journal-title":"J Cell Biol"},{"key":"8036_CR200","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1523\/JNEUROSCI.23-12-05020.2003","volume":"23","author":"N Bizat","year":"2003","unstructured":"Bizat N (2003) Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington\u2019s disease. J Neurosci 23:5020\u20135030","journal-title":"J Neurosci"},{"key":"8036_CR201","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","volume":"279","author":"J Gafni","year":"2004","unstructured":"Gafni J (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus. J Biol Chem 279:20211\u201320220","journal-title":"J Biol Chem"},{"key":"8036_CR202","doi-asserted-by":"crossref","first-page":"43245","DOI":"10.1074\/jbc.M305057200","volume":"278","author":"N Bizat","year":"2003","unstructured":"Bizat N (2003) In vivo calpain\/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3. J Biol Chem 278:43245\u201343253","journal-title":"J Biol Chem"},{"key":"8036_CR203","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuropharm.2005.04.030","volume":"49","author":"N Bizat","year":"2005","unstructured":"Bizat N (2005) Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain. Neuropharmacology 49:695\u2013702","journal-title":"Neuropharmacology"},{"key":"8036_CR204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2007.05.038","volume":"421","author":"N Crespo-Biel","year":"2007","unstructured":"Crespo-Biel N (2007) 3-Nitropropionic acid activates calpain\/cdk5 pathway in rat striatum. Neurosci Lett 421:77\u201381","journal-title":"Neurosci Lett"},{"key":"8036_CR205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1083\/jcb.200412071","volume":"169","author":"S Luo","year":"2005","unstructured":"Luo S (2005) Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J Cell Biol 169:647\u2013656","journal-title":"J Cell Biol"},{"key":"8036_CR206","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1523\/JNEUROSCI.1831-07.2007","volume":"27","author":"SL Anne","year":"2007","unstructured":"Anne SL (2007) Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J Neurosci 27:7318\u20137328","journal-title":"J Neurosci"},{"key":"8036_CR207","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","volume":"354","author":"EM Frohman","year":"2006","unstructured":"Frohman EM (2006) Multiple sclerosis\u2014the plaque and its pathogenesis. N Engl J Med 354:942\u2013955","journal-title":"N Engl J Med"},{"key":"8036_CR208","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH (2000) Multiple sclerosis. N Engl J Med 343:938\u2013952","journal-title":"N Engl J Med"},{"key":"8036_CR209","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0090-1229(91)90147-3","volume":"58","author":"W Ofosu-Appiah","year":"1991","unstructured":"Ofosu-Appiah W (1991) Characterization of in vivo-activated T cell clones from peripheral blood of multiple sclerosis patients. Clin Immunol Immunopathol 58:46\u201355","journal-title":"Clin Immunol Immunopathol"},{"key":"8036_CR210","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra M (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683\u2013747","journal-title":"Annu Rev Immunol"},{"key":"8036_CR211","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.clineuro.2004.02.007","volume":"106","author":"A Compston","year":"2004","unstructured":"Compston A (2004) The pathogenesis and basis for treatment in multiple sclerosis. Clin Neurol Neurosurg 106:246\u2013248","journal-title":"Clin Neurol Neurosurg"},{"issue":"Suppl 2","key":"8036_CR212","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1073\/pnas.0404874101","volume":"101","author":"R Hohlfeld","year":"2004","unstructured":"Hohlfeld R (2004) Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc Natl Acad Sci U S A 101(Suppl 2):14599\u201314606","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR213","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0404.1987.tb03538.x","volume":"76","author":"T Inuzuka","year":"1987","unstructured":"Inuzuka T (1987) Neutral protease in cerebrospinal fluid from patients with multiple sclerosis and other neurological diseases. Acta Neurol Scand 76:18\u201323","journal-title":"Acta Neurol Scand"},{"key":"8036_CR214","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/(SICI)1097-4547(19990301)55:5<533::AID-JNR1>3.0.CO;2-8","volume":"55","author":"DC Shields","year":"1999","unstructured":"Shields DC (1999) Pathophysiological role of calpain in experimental demyelination. J Neurosci Res 55:533\u2013541","journal-title":"J Neurosci Res"},{"key":"8036_CR215","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/eji.1830240619","volume":"24","author":"E Clementi","year":"1994","unstructured":"Clementi E (1994) Intracellular Ca2+ stores of T lymphocytes: changes induced by in vitro and in vivo activation. Eur J Immunol 24:1365\u20131371","journal-title":"Eur J Immunol"},{"key":"8036_CR216","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/BF00966771","volume":"18","author":"RV Deshpande","year":"1993","unstructured":"Deshpande RV (1993) Differential distribution of calpain in human lymphoid cells. Neurochem Res 18:767\u2013773","journal-title":"Neurochem Res"},{"key":"8036_CR217","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1074\/jbc.270.6.2497","volume":"270","author":"RV Deshpande","year":"1995","unstructured":"Deshpande RV (1995) Calpain expression in lymphoid cells. Increased mRNA and protein levels after cell activation. J Biol Chem 270:2497\u20132505","journal-title":"J Biol Chem"},{"key":"8036_CR218","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jnr.490420214","volume":"42","author":"RV Deshpande","year":"1995","unstructured":"Deshpande RV (1995) Calpain secreted by activated human lymphoid cells degrades myelin. J Neurosci Res 42:259\u2013265","journal-title":"J Neurosci Res"},{"key":"8036_CR219","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0006-8993(98)00193-0","volume":"794","author":"DC Shields","year":"1998","unstructured":"Shields DC (1998) Upregulation of calpain activity and expression in experimental allergic encephalomyelitis: a putative role for calpain in demyelination. Brain Res 794:68\u201374","journal-title":"Brain Res"},{"key":"8036_CR220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0006-8993(97)01381-4","volume":"784","author":"DC Shields","year":"1998","unstructured":"Shields DC (1998) Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study. Brain Res 784:299\u2013304","journal-title":"Brain Res"},{"key":"8036_CR221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(02)00142-X","volume":"129","author":"K Schaecher","year":"2002","unstructured":"Schaecher K (2002) Calpain expression and infiltration of activated T cells in experimental allergic encephalomyelitis over time: increased calpain activity begins with onset of disease. J Neuroimmunol 129:1\u20139","journal-title":"J Neuroimmunol"},{"key":"8036_CR222","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1196\/annals.1344.005","volume":"1053","author":"MK Guyton","year":"2005","unstructured":"Guyton MK (2005) A role for calpain in optic neuritis. Ann N Y Acad Sci 1053:48\u201354","journal-title":"Ann N Y Acad Sci"},{"key":"8036_CR223","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jnr.20470","volume":"81","author":"MK Guyton","year":"2005","unstructured":"Guyton MK (2005) Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J Neurosci Res 81:53\u201361","journal-title":"J Neurosci Res"},{"key":"8036_CR224","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00401-006-0045-0","volume":"111","author":"M Diaz-Sanchez","year":"2006","unstructured":"Diaz-Sanchez M (2006) Protein co-expression with axonal injury in multiple sclerosis plaques. Acta Neuropathol 111:289\u2013299","journal-title":"Acta Neuropathol"},{"key":"8036_CR225","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.1073\/pnas.96.20.11486","volume":"96","author":"DC Shields","year":"1999","unstructured":"Shields DC (1999) A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc Natl Acad Sci U S A 96:11486\u201311491","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR226","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1096\/fasebj.9.15.8529837","volume":"9","author":"EN Benveniste","year":"1995","unstructured":"Benveniste EN (1995) TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function. Faseb J 9:1577\u20131584","journal-title":"Faseb J"},{"key":"8036_CR227","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1022478005243","volume":"23","author":"ME Smith","year":"1998","unstructured":"Smith ME (1998) Effects of phorbol myristate acetate (PMA) on functions of macrophages and microglia in vitro. Neurochem Res 23:427\u2013434","journal-title":"Neurochem Res"},{"key":"8036_CR228","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1021612615554","volume":"28","author":"JA Benjamins","year":"2003","unstructured":"Benjamins JA (2003) Protection of mature oligodendrocytes by inhibitors of caspases and calpains. Neurochem Res 28:143\u2013152","journal-title":"Neurochem Res"},{"key":"8036_CR229","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/brain\/awh627","volume":"128","author":"A Jurewicz","year":"2005","unstructured":"Jurewicz A (2005) Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 128:2675\u20132688","journal-title":"Brain"},{"key":"8036_CR230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2006.02.051","volume":"1084","author":"A Das","year":"2006","unstructured":"Das A (2006) Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res 1084:146\u2013157","journal-title":"Brain Res"},{"key":"8036_CR231","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2006.08.005","volume":"180","author":"GW Hassen","year":"2006","unstructured":"Hassen GW (2006) A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis. J Neuroimmunol 180:135\u2013146","journal-title":"J Neuroimmunol"},{"key":"8036_CR232","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2007.07.016","volume":"190","author":"SA Imam","year":"2007","unstructured":"Imam SA (2007) Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. J Neuroimmunol 190:139\u2013145","journal-title":"J Neuroimmunol"},{"key":"8036_CR233","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363\u201313383","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR234","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ncl.2007.03.006","volume":"25","author":"E Eggenberger","year":"2007","unstructured":"Eggenberger E (2007) Prion disease. Neurol Clin 25:833\u2013842 viii","journal-title":"Neurol Clin"},{"key":"8036_CR235","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1006\/jmbi.1999.2831","volume":"289","author":"F Wopfner","year":"1999","unstructured":"Wopfner F (1999) Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 289:1163\u20131178","journal-title":"J Mol Biol"},{"key":"8036_CR236","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1073\/pnas.95.15.8812","volume":"95","author":"G Zanusso","year":"1998","unstructured":"Zanusso G (1998) Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A 95:8812\u20138816","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR237","doi-asserted-by":"crossref","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","volume":"270","author":"SG Chen","year":"1995","unstructured":"Chen SG (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270:19173\u201319180","journal-title":"J Biol Chem"},{"key":"8036_CR238","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1073725","volume":"298","author":"J Ma","year":"2002","unstructured":"Ma J (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781\u20131785","journal-title":"Science"},{"key":"8036_CR239","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1074\/jbc.M410649200","volume":"280","author":"X Wang","year":"2005","unstructured":"Wang X (2005) Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol. J Biol Chem 280:317\u2013325","journal-title":"J Biol Chem"},{"key":"8036_CR240","doi-asserted-by":"crossref","first-page":"35914","DOI":"10.1074\/jbc.M507327200","volume":"280","author":"NT Watt","year":"2005","unstructured":"Watt NT (2005) Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J Biol Chem 280:35914\u201335921","journal-title":"J Biol Chem"},{"key":"8036_CR241","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1212\/WNL.43.11.2335","volume":"43","author":"K Kristensson","year":"1993","unstructured":"Kristensson K (1993) Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 43:2335\u20132341","journal-title":"Neurology"},{"key":"8036_CR242","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(00)00366-6","volume":"399","author":"YF Xiao","year":"2000","unstructured":"Xiao YF (2000) Mechanism of suppression of cardiac L-type Ca(2+) currents by the phospholipase A(2) inhibitor mepacrine. Eur J Pharmacol 399:107\u2013116","journal-title":"Eur J Pharmacol"},{"key":"8036_CR243","doi-asserted-by":"crossref","first-page":"43516","DOI":"10.1074\/jbc.M103894200","volume":"276","author":"CN O\u2019Donovan","year":"2001","unstructured":"O\u2019Donovan CN (2001) Prion protein fragment PrP-(106\u2013126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J Biol Chem 276:43516\u201343523","journal-title":"J Biol Chem"},{"key":"8036_CR244","doi-asserted-by":"crossref","first-page":"21948","DOI":"10.1074\/jbc.M400793200","volume":"279","author":"R Yadavalli","year":"2004","unstructured":"Yadavalli R (2004) Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J Biol Chem 279:21948\u201321956","journal-title":"J Biol Chem"},{"key":"8036_CR245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/BST0340051","volume":"34","author":"BC Gray","year":"2006","unstructured":"Gray BC (2006) Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice. Biochem Soc Trans 34:51\u201354","journal-title":"Biochem Soc Trans"},{"key":"8036_CR246","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1999.7041","volume":"157","author":"S Du","year":"1999","unstructured":"Du S (1999) Calcium influx and activation of calpain I mediate acute reactive gliosis in injured spinal cord. Exp Neurol 157:96\u2013105","journal-title":"Exp Neurol"},{"key":"8036_CR247","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0006-8993(00)02180-6","volume":"864","author":"YB Lee","year":"2000","unstructured":"Lee YB (2000) Rapid increase in immunoreactivity to GFAP in astrocytes in vitro induced by acidic pH is mediated by calcium influx and calpain I. Brain Res 864:220\u2013229","journal-title":"Brain Res"},{"key":"8036_CR248","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","volume":"8","author":"M Riemenschneider","year":"2003","unstructured":"Riemenschneider M (2003) Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt\u2013Jakob disease from other dementias. Mol Psychiatry 8:343\u2013347","journal-title":"Mol Psychiatry"},{"key":"8036_CR249","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0896-6273(00)81108-3","volume":"24","author":"DW Cleveland","year":"1999","unstructured":"Cleveland DW (1999) From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24:515\u2013520","journal-title":"Neuron"},{"key":"8036_CR250","first-page":"17","volume":"1","author":"AC Ludolph","year":"2000","unstructured":"Ludolph AC (2000) The role of excitotoxicity in ALS\u2014what is the evidence? J Neurol 247 Suppl 1:17\u201316","journal-title":"J Neurol 247 Suppl"},{"key":"8036_CR251","first-page":"59","volume":"13","author":"AC Ludolph","year":"1998","unstructured":"Ludolph AC (1998) Amyotrophic lateral sclerosis and glutamate. Restor Neurol Neurosci 13:59\u201367","journal-title":"Restor Neurol Neurosci"},{"key":"8036_CR252","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ana.410360608","volume":"36","author":"ME Alexianu","year":"1994","unstructured":"Alexianu ME (1994) The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 36:846\u2013858","journal-title":"Ann Neurol"},{"key":"8036_CR253","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00005072-199806000-00005","volume":"57","author":"L Siklos","year":"1998","unstructured":"Siklos L (1998) Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. J Neuropathol Exp Neurol 57:571\u2013587","journal-title":"J Neuropathol Exp Neurol"},{"key":"8036_CR254","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1471-4159.2001.00582.x","volume":"79","author":"DR Beers","year":"2001","unstructured":"Beers DR (2001) Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J Neurochem 79:499\u2013509","journal-title":"J Neurochem"},{"key":"8036_CR255","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/0024-3205(86)90331-0","volume":"39","author":"MN Malik","year":"1986","unstructured":"Malik MN (1986) Purification and degradation of purified neurofilament proteins by the brain calcium-activated neutral proteases. Life Sci 39:1335\u20131343","journal-title":"Life Sci"},{"key":"8036_CR256","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/bj2560665","volume":"256","author":"HC Pant","year":"1988","unstructured":"Pant HC (1988) Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem J 256:665\u2013668","journal-title":"Biochem J"},{"key":"8036_CR257","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/BF00965535","volume":"16","author":"GV Johnson","year":"1991","unstructured":"Johnson GV (1991) The regulatory role of calmodulin in the proteolysis of individual neurofilament proteins by calpain. Neurochem Res 16:869\u2013873","journal-title":"Neurochem Res"},{"key":"8036_CR258","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1046\/j.1471-4159.2001.00094.x","volume":"76","author":"MJ Strong","year":"2001","unstructured":"Strong MJ (2001) Phosphorylation state of the native high-molecular-weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis. J Neurochem 76:1315\u20131325","journal-title":"J Neurochem"},{"key":"8036_CR259","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0278-5846(99)00044-5","volume":"23","author":"NP Bajaj","year":"1999","unstructured":"Bajaj NP (1999) Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS. Prog Neuropsychopharmacol Biol Psychiatry 23:833\u2013850","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8036_CR260","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0896-6273(01)00268-9","volume":"30","author":"MD Nguyen","year":"2001","unstructured":"Nguyen MD (2001) Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30:135\u2013147","journal-title":"Neuron"},{"key":"8036_CR261","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1073\/pnas.95.16.9626","volume":"95","author":"S Couillard-Despres","year":"1998","unstructured":"Couillard-Despres S (1998) Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc Natl Acad Sci U S A 95:9626\u20139630","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR262","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1046\/j.1471-4159.2003.02256.x","volume":"88","author":"S Takahashi","year":"2004","unstructured":"Takahashi S (2004) Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25. J Neurochem 88:1295\u20131304","journal-title":"J Neurochem"},{"key":"8036_CR263","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.yexcr.2006.02.021","volume":"312","author":"H Wootz","year":"2006","unstructured":"Wootz H (2006) XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. Exp Cell Res 312:1890\u20131898","journal-title":"Exp Cell Res"},{"key":"8036_CR264","first-page":"25","volume":"50","author":"S Cardali","year":"2006","unstructured":"Cardali S (2006) Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. J Neurosurg Sci 50:25\u201331","journal-title":"J Neurosurg Sci"},{"key":"8036_CR265","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3171\/JNS-07\/10\/0792","volume":"107","author":"SB Lewis","year":"2007","unstructured":"Lewis SB (2007) Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury. J Neurosurg 107:792\u2013796","journal-title":"J Neurosurg"},{"key":"8036_CR266","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.jcbfm.9600138","volume":"25","author":"R Siman","year":"2005","unstructured":"Siman R (2005) Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat. J Cereb Blood Flow Metab 25:1433\u20131444","journal-title":"J Cereb Blood Flow Metab"},{"key":"8036_CR267","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1074\/jbc.M413269200","volume":"280","author":"BM Polster","year":"2005","unstructured":"Polster BM (2005) Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem 280:6447\u20136454","journal-title":"J Biol Chem"},{"key":"8036_CR268","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1046\/j.1471-4159.2001.00503.x","volume":"78","author":"C Reimertz","year":"2001","unstructured":"Reimertz C (2001) Ca(2+)-induced inhibition of apoptosis in human SH-SY5Y neuroblastoma cells: degradation of apoptotic protease activating factor-1 (APAF-1). J Neurochem 78:1256\u20131266","journal-title":"J Neurochem"},{"key":"8036_CR269","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1046\/j.1471-4159.2001.00368.x","volume":"77","author":"WS Choi","year":"2001","unstructured":"Choi WS (2001) Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J Neurochem 77:1531\u20131541","journal-title":"J Neurochem"},{"key":"8036_CR270","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.onc.1202034","volume":"17","author":"DE Wood","year":"1998","unstructured":"Wood DE (1998) Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17:1069\u20131078","journal-title":"Oncogene"},{"key":"8036_CR271","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1083\/jcb.150.4.887","volume":"150","author":"T Nakagawa","year":"2000","unstructured":"Nakagawa T (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150:887\u2013894","journal-title":"J Cell Biol"},{"key":"8036_CR272","doi-asserted-by":"crossref","first-page":"16175","DOI":"10.1074\/jbc.M414552200","volume":"280","author":"J Takano","year":"2005","unstructured":"Takano J (2005) Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J Biol Chem 280:16175\u201316184","journal-title":"J Biol Chem"},{"key":"8036_CR273","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.152336999","volume":"99","author":"MJ Kim","year":"2002","unstructured":"Kim MJ (2002) Calpain-dependent cleavage of cain\/cabin1 activates calcineurin to mediate calcium-triggered cell death. Proc Natl Acad Sci U S A 99:9870\u20139875","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8036_CR274","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0169-328X(91)90015-P","volume":"11","author":"J Covault","year":"1991","unstructured":"Covault J (1991) Calcium-activated proteolysis of intracellular domains in the cell adhesion molecules NCAM and N-cadherin. Brain Res Mol Brain Res 11:11\u201316","journal-title":"Brain Res Mol Brain Res"},{"key":"8036_CR275","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1471-4159.1997.69031006.x","volume":"69","author":"I Hajimohammadreza","year":"1997","unstructured":"Hajimohammadreza I (1997) Neuronal nitric oxide synthase and calmodulin-dependent protein kinase IIalpha undergo neurotoxin-induced proteolysis. J Neurochem 69:1006\u20131013","journal-title":"J Neurochem"},{"key":"8036_CR276","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/bi00406a059","volume":"27","author":"EA Tallant","year":"1988","unstructured":"Tallant EA (1988) Activation of a calmodulin-dependent phosphatase by a Ca2+-dependent protease. Biochemistry 27:2205\u20132211","journal-title":"Biochemistry"},{"key":"8036_CR277","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1074\/jbc.M007807200","volume":"276","author":"K Blomgren","year":"2001","unstructured":"Blomgren K (2001) Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of \u201cpathological apoptosis\u201d? J Biol Chem 276:10191\u201310198","journal-title":"J Biol Chem"},{"key":"8036_CR278","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1074\/jbc.275.7.5131","volume":"275","author":"BT Chua","year":"2000","unstructured":"Chua BT (2000) Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 275:5131\u20135135","journal-title":"J Biol Chem"},{"key":"8036_CR279","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1093\/emboj\/18.18.4988","volume":"18","author":"A Ruiz-Vela","year":"1999","unstructured":"Ruiz-Vela A (1999) Implication of calpain in caspase activation during B cell clonal deletion. Embo J 18:4988\u20134998","journal-title":"Embo J"},{"key":"8036_CR280","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1471-4159.2005.03122.x","volume":"93","author":"C Volbracht","year":"2005","unstructured":"Volbracht C (2005) The critical role of calpain versus caspase activation in excitotoxic injury induced by nitric oxide. J Neurochem 93:1280\u20131292","journal-title":"J Neurochem"},{"key":"8036_CR281","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/47513","volume":"403","author":"T Nakagawa","year":"2000","unstructured":"Nakagawa T (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98\u2013103","journal-title":"Nature"},{"key":"8036_CR282","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.expneurol.2004.05.020","volume":"189","author":"M Krajewska","year":"2004","unstructured":"Krajewska M (2004) Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitation. Exp Neurol 189:261\u2013279","journal-title":"Exp Neurol"},{"key":"8036_CR283","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbrc.2006.12.061","volume":"353","author":"H Ohno","year":"2007","unstructured":"Ohno H (2007) Ischemia promotes calpain-mediated degradation of p120-catenin in SH-SY5Y cells. Biochem Biophys Res Commun 353:547\u2013552","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR284","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-0102(01)00201-2","volume":"39","author":"VV Zakharov","year":"2001","unstructured":"Zakharov VV (2001) Site-specific calcium-dependent proteolysis of neuronal protein GAP-43. Neurosci Res 39:447\u2013453","journal-title":"Neurosci Res"},{"key":"8036_CR285","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1471-4159.2007.04452.x","volume":"101","author":"VV Zakharov","year":"2007","unstructured":"Zakharov VV (2007) M-calpain-mediated cleavage of GAP-43 near Ser41 is negatively regulated by protein kinase C, calmodulin and calpain-inhibiting fragment GAP-43\u20133. J Neurochem 101:1539\u20131551","journal-title":"J Neurochem"},{"key":"8036_CR286","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1113\/jphysiol.2006.122754","volume":"580","author":"EY Yuen","year":"2007","unstructured":"Yuen EY (2007) Calpain regulation of AMPA receptor channels in cortical pyramidal neurons. J Physiol 580:241\u2013254","journal-title":"J Physiol"},{"key":"8036_CR287","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1016\/S0021-9258(19)38867-2","volume":"265","author":"SY Lee","year":"1990","unstructured":"Lee SY (1990) Purification and properties of D-myo-inositol 1,4,5-trisphosphate 3-kinase from rat brain. Susceptibility to calpain. J Biol Chem 265:9434\u20139440","journal-title":"J Biol Chem"},{"key":"8036_CR288","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1016\/S0021-9258(19)39435-9","volume":"265","author":"Y Yoshihara","year":"1990","unstructured":"Yoshihara Y (1990) Purification of a novel type of calcium-activated neutral protease from rat brain. Possible involvement in production of the neuropeptide kyotorphin from calpastatin fragments. J Biol Chem 265:5809\u20135815","journal-title":"J Biol Chem"},{"key":"8036_CR289","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0006-291X(88)80529-1","volume":"155","author":"Y Yoshihara","year":"1988","unstructured":"Yoshihara Y (1988) Calcium-activated neutral protease (CANP), a putative processing enzyme of the neuropeptide, kyotorphin, in the brain. Biochem Biophys Res Commun 155:546\u2013553","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR290","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1247\/csf.11.253","volume":"11","author":"C Sato","year":"1986","unstructured":"Sato C (1986) Rapid proteolysis of brain MAP-1 related cytoskeleton-associated 350\u00a0kd protein by purified calpain. Cell Struct Funct 11:253\u2013257","journal-title":"Cell Struct Funct"},{"key":"8036_CR291","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.STR.21.6.917","volume":"21","author":"T Inuzuka","year":"1990","unstructured":"Inuzuka T (1990) Changes in the concentrations of cerebral proteins following occlusion of the middle cerebral artery in rats. Stroke 21:917\u2013922","journal-title":"Stroke"},{"key":"8036_CR292","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00005072-199601000-00007","volume":"55","author":"RM Posmantur","year":"1996","unstructured":"Posmantur RM (1996) Cytoskeletal derangements of cortical neuronal processes three hours after traumatic brain injury in rats: an immunofluorescence study. J Neuropathol Exp Neurol 55:68\u201380","journal-title":"J Neuropathol Exp Neurol"},{"key":"8036_CR293","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1523\/JNEUROSCI.3722-04.2004","volume":"24","author":"YN Dong","year":"2004","unstructured":"Dong YN (2004) Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. J Neurosci 24:11035\u201311045","journal-title":"J Neurosci"},{"key":"8036_CR294","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1074\/jbc.270.9.4318","volume":"270","author":"Y Banno","year":"1995","unstructured":"Banno Y (1995) Endogenous cleavage of phospholipase C-beta 3 by agonist-induced activation of calpain in human platelets. J Biol Chem 270:4318\u20134324","journal-title":"J Biol Chem"},{"key":"8036_CR295","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/bj2210813","volume":"221","author":"MG Low","year":"1984","unstructured":"Low MG (1984) Multiple forms of phosphoinositide-specific phospholipase C of different relative molecular masses in animal tissues. Evidence for modification of the platelet enzyme by Ca2+-dependent proteinase. Biochem J 221:813\u2013820","journal-title":"Biochem J"},{"key":"8036_CR296","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1016\/S0021-9258(18)53751-0","volume":"268","author":"D Park","year":"1993","unstructured":"Park D (1993) Removal of the carboxyl-terminal region of phospholipase C-beta 1 by calpain abolishes activation by G alpha q. J Biol Chem 268:3710\u20133714","journal-title":"J Biol Chem"},{"key":"8036_CR297","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0197-4580(02)00060-X","volume":"24","author":"B Boland","year":"2003","unstructured":"Boland B (2003) beta-Amyloid (1\u201340)-induced apoptosis of cultured cortical neurones involves calpain-mediated cleavage of poly-ADP-ribose polymerase. Neurobiol Aging 24:179\u2013186","journal-title":"Neurobiol Aging"},{"key":"8036_CR298","first-page":"55","volume":"36","author":"K Mikawa","year":"1990","unstructured":"Mikawa K (1990) Studies on proteolysis of protein kinase C with calpain I and II. Kobe J Med Sci 36:55\u201369","journal-title":"Kobe J Med Sci"},{"key":"8036_CR299","first-page":"109","volume":"14","author":"JS Sessoms","year":"1992","unstructured":"Sessoms JS (1992) Ca(2+)-induced persistent protein kinase C activation in rat hippocampal homogenates. Second Messengers Phosphoprot 14:109\u2013126","journal-title":"Second Messengers Phosphoprot"},{"key":"8036_CR300","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0197-0186(02)00096-7","volume":"42","author":"M Ziemka-Nalecz","year":"2003","unstructured":"Ziemka-Nalecz M (2003) Decrease of PKC precedes other cellular signs of calpain activation in area CA1 of the hippocampus after transient cerebral ischemia. Neurochem Int 42:205\u2013214","journal-title":"Neurochem Int"},{"key":"8036_CR301","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(00)01101-0","volume":"286","author":"X Lu","year":"2000","unstructured":"Lu X (2000) Calpain-mediated degradation of PSD-95 in developing and adult rat brain. Neurosci Lett 286:149\u2013153","journal-title":"Neurosci Lett"},{"key":"8036_CR302","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuint.2004.07.002","volume":"46","author":"H Jourdi","year":"2005","unstructured":"Jourdi H (2005) Effects of positive AMPA receptor modulators on calpain-mediated spectrin degradation in cultured hippocampal slices. Neurochem Int 46:31\u201340","journal-title":"Neurochem Int"},{"key":"8036_CR303","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/0006-291X(89)91150-9","volume":"163","author":"GV Johnson","year":"1989","unstructured":"Johnson GV (1989) Proteolysis of tau by calpain. Biochem Biophys Res Commun 163:1505\u20131511","journal-title":"Biochem Biophys Res Commun"},{"key":"8036_CR304","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-4547(19980715)53:2<153::AID-JNR4>3.0.CO;2-6","volume":"53","author":"HQ Xie","year":"1998","unstructured":"Xie HQ (1998) Calcineurin inhibition prevents calpain-mediated proteolysis of tau in differentiated PC12 cells. J Neurosci Res 53:153\u2013164","journal-title":"J Neurosci Res"},{"key":"8036_CR305","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0143-4160(88)90036-X","volume":"9","author":"M Billger","year":"1988","unstructured":"Billger M (1988) Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Difference in sensitivity of assembled and disassembled microtubules. Cell Calcium 9:33\u201344","journal-title":"Cell Calcium"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-008-8036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-008-8036-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-008-8036-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T10:59:44Z","timestamp":1631617184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-008-8036-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":305,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["8036"],"URL":"https:\/\/doi.org\/10.1007\/s12035-008-8036-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}